Member Info for Mulder

Trading at levels not seen for 4.5 years. Not far off its book price of 1022p and yes that includes intangibles/goodwill but this amount/ratio is less than its peers. It really does become an irrational, manipulated market when enough shorters get involved with a stock.

EPS 6.4p Dividend 3.4p so 1.9x cover (ample) Current Dividend yield >8%** P/E 6.4** (extremely low; peers trading on 12-13x) Share price 41p So a P/E of 6 and a dividend yielding over 8% that is almost twice covered by earnings. The only anomaly I can see here is the current share price! SP should be 60p+ but this again highlights how shorts automatically manipulate and suppress the SP regardless of fundamentals. Thoughts?

Even if Shire lost its entire Haematology business to competitors like Roche it is still trading at a steep discount to peers. Brokers like Credit Suisse said only last week even in a worst case scenario Shire should be trading at 4600p+ Illogical and irrational market behaviour again.

The mini rally did not last long. notgreedy back shorting?

It is nearly always the case that the company buying will see its share price fall due to the extra debt they will be taking on and the premium they often pay.

SHIRE READY TO FLY https://seekingalpha.com/article/4118487-shire-q3-2017-ready-fly **Non GAAP Net Debt has been reduced by $0.92B in Q3/2017, driven by a really strong free cash flow generation of $1.05B. Thus, it looks like that the company will be able to achieve its target of 2-3x net debt to EBITDA leverage by end 2017. Analysis shows that even assuming a conservative 6/8x P/E valuation to Rare Disease and Heamophilia franchises, the stock is undervalued by at least 35%.*** Multiples Comparison Lastly, Shire has traded historically at 15.3x NTM (next twelve months) P/E, which was below the Spec pharma group. Today, Shire is trading at a discount to its 5-year average historical P/E on an absolute and relative basis, as shown by the following analysis. In particular, the stock is trading at 9.1x NTM (next twelve months) P/E, which is at 40% of discount vs. its historical valuation.****

Ex-dividend moved up a day earlier also to 7th Dec. Final dividend now yielding 5.5% at current SP.

The volatility here is ridiculous for what should be a defensive low beta share. 294p to 275p in 24hours - 7% swing based on what exactly?

It would not be unreasonable for this to be trading on a P/E of at least 15 as opposed to the current 11 based on EPS of 120p. That would put this back at 1800p Accenture also sniffing around looking at a bid which would need to be around 2000p IMO Sorrell stated catalysts for 2018 including FIFA Football World Cup and Winter Olympics.

Large discrepancy of 1% between Nasdaq and FTSE today. Strange.

Even with flat EPS trading on a P/E around 10 and yielding around 5%. Was 1900+ few months back.

RE: Any dividend? How does a 8% dividend sound?!

Check the posts from below - all the information is there.

As to valuation last year EPS was 6.4p Current P/E is therefore just 6.9 Just to highlight how low the current SP is let us be really bearish and project full year EPS next year will be around 5p (22% fall) That still leaves the shares on a P/E around 9 and dividend covered 1.5x Peers are trading on P/E's around 12 so as a very minimum SP here should be 60p.

Thanks for that Fruitster. I do not like the way shorters (when in large enough numbers) 'control' the SP though and hold it down suppressing rises and on a day like today causing a large 6% fall on little to no news! Do you agree share price manipulation goes on all the time despite the FCA denying this and calling it a 'fair' and 'regulated market'? 6% fall today is obscene for example and unjustified. Similarly on results day most expected a cut in the dividend yet despite the good news there was no 'relief rally' due to these guys clamping the SP. Just as the recent rise from 40p to 50p was based on nothing - rose 25% in 2 weeks on no news. Ex-dividend 2.4p 8th December Yielding 5.5% alone - far higher than a savings account.

Equity of �918M and an equity ratio of 1.71 which yes includes 40% of intangibles/goodwill. Debenhams however does have a long history and is a global brand, just opening its first store in Australia. Given your accounting background can you explain why shorters will attack a company like this now trading on a P/E of just 6 and yielding close to 8% almost twice covered by earnings? Yet will not go after companies trading on P/E's far higher, perhaps as high as 100?

Sylvania Platinum Ltd SLP Liberum Capital Buy 11.38 11.75 18.00 18.00 Reiterates

Close those shorts! ********************************************** Sports Direct is committed to buying 10.5 per cent of Debenhams� shares in 10 transactions during October and November. The price, which was agreed more than two years ago, has not been disclosed. However, Sports Direct warned in 2015 that it could be forced to pay more than the market price for Debenhams shares when the options matured.�It said its maximum exposure, net of fees it was receiving from Goldman, was �85m, which equates to 65.9p per Debenhams share. CEO on Ashley �[He] is a very smart investor and he sees value in our shares,� Mr Bucher said. �He sees the upside.�

Can someone post the article from today if possible. Thanks.

Increase from £1.2Bn to £1.4Bn should not be a big deal.